{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:06:24Z","timestamp":1791331584399,"version":"4.3.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T00:00:00Z","timestamp":1327017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2011.53","type":"journal-article","created":{"date-parts":[[2012,1,20]],"date-time":"2012-01-20T14:20:43Z","timestamp":1327069243000},"page":"e52-e52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Entourage: the immune microenvironment following follicular lymphoma"],"prefix":"10.1038","volume":"2","author":[{"given":"B E","family":"Wahlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Sander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Christensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"\u00d8stenstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Holte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P D","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kimby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,1,20]]},"reference":[{"key":"BFbcj201153_CR1","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1182\/blood-2007-10-115915","volume":"111","author":"RJ Byers","year":"2008","unstructured":"Byers RJ, Sakhinia E, Joseph P, Glennie C, Hoyland JA, Menasce LP et al. Clinical quantitation of immune signature in follicular lymphoma by RT-PCR-based gene expression profiling. Blood 2008; 111: 4764\u20134770.","journal-title":"Blood"},{"key":"BFbcj201153_CR2","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1158\/1078-0432.CCR-09-2487","volume":"16","author":"BE Wahlin","year":"2010","unstructured":"Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L et al. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1-positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res 2010; 16: 637\u2013650.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201153_CR3","doi-asserted-by":"publisher","first-page":"5350","DOI":"10.1200\/JCO.2006.06.4766","volume":"24","author":"T Alvaro","year":"2006","unstructured":"Alvaro T, Lejeune M, Salvado MT, Lopez C, Jaen J, Bosch R et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol 2006; 24: 5350\u20135357.","journal-title":"J Clin Oncol"},{"key":"BFbcj201153_CR4","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1158\/1078-0432.CCR-06-1734","volume":"13","author":"BE Wahlin","year":"2007","unstructured":"Wahlin BE, Sander B, Christensson B, Kimby E . CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res 2007; 13: 388\u2013397.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201153_CR5","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1200\/JCO.2006.06.1648","volume":"25","author":"AM Glas","year":"2007","unstructured":"Glas AM, Knoops L, Delahaye L, Kersten MJ, Kibbelaar RE, Wessels LA et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol 2007; 25: 390\u2013398.","journal-title":"J Clin Oncol"},{"key":"BFbcj201153_CR6","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V82.6.1848.1848","volume":"82","author":"PW Johnson","year":"1993","unstructured":"Johnson PW, Watt SM, Betts DR, Davies D, Jordan S, Norton AJ et al. Isolated follicular lymphoma cells are resistant to apoptosis and can be grown in vitro in the CD40\/stromal cell system. Blood 1993; 82: 1848\u20131857.","journal-title":"Blood"},{"key":"BFbcj201153_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/(SICI)1099-1069(199711)15:4<197::AID-HON614>3.0.CO;2-V","volume":"15","author":"D Schmitter","year":"1997","unstructured":"Schmitter D, Koss M, Niederer E, Stahel RA, Pichert G . T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells. Hematol Oncol 1997; 15: 197\u2013207.","journal-title":"Hematol Oncol"},{"key":"BFbcj201153_CR8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1182\/blood.V91.1.244","volume":"91","author":"P Ghia","year":"1998","unstructured":"Ghia P, Boussiotis VA, Schultze JL, Cardoso AA, Dorfman DM, Gribben JG et al. Unbalanced expression of bcl-2 family proteins in follicular lymphoma: contribution of CD40 signaling in promoting survival. Blood 1998; 91: 244\u2013251.","journal-title":"Blood"},{"key":"BFbcj201153_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.4049\/jimmunol.181.2.1001","volume":"181","author":"M Travert","year":"2008","unstructured":"Travert M, Ame-Thomas P, Pangault C, Morizot A, Micheau O, Semana G et al. CD40 ligand protects from TRAIL-induced apoptosis in follicular lymphomas through NF-kappaB activation and up-regulation of c-FLIP and Bcl-xL. J Immunol 2008; 181: 1001\u20131011.","journal-title":"J Immunol"},{"key":"BFbcj201153_CR10","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.4049\/jimmunol.144.7.2550","volume":"144","author":"DT Umetsu","year":"1990","unstructured":"Umetsu DT, Esserman L, Donlon TA, DeKruyff RH, Levy R . Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol 1990; 144: 2550\u20132557.","journal-title":"J Immunol"},{"key":"BFbcj201153_CR11","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/leu.2010.223","volume":"24","author":"C Pangault","year":"2010","unstructured":"Pangault C, Ame-Thomas P, Ruminy P, Rossille D, Caron G, Baia M et al. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis. Leukemia 2010; 24: 2080\u20132089.","journal-title":"Leukemia"},{"key":"BFbcj201153_CR12","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1038\/sj.leu.2400822","volume":"11","author":"C Buske","year":"1997","unstructured":"Buske C, Twiling A, Gogowski G, Schreiber K, Feuring-Buske M, Wulf GG et al. In vitro activation of low-grade non-Hodgkin\u2032s lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand. Leukemia 1997; 11: 1862\u20131867.","journal-title":"Leukemia"},{"key":"BFbcj201153_CR13","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1158\/0008-5472.CAN-08-3000","volume":"69","author":"H Maby-El Hajjami","year":"2009","unstructured":"Maby-El Hajjami H, Ame-Thomas P, Pangault C, Tribut O, DeVos J, Jean R et al. Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase. Cancer Res 2009; 69: 3228\u20133237.","journal-title":"Cancer Res"},{"issue":"1","key":"BFbcj201153_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/leu.2011.179","volume":"26","author":"G Epron","year":"2011","unstructured":"Epron G, Ame-Thomas P, Le Priol J, Pangault C, Dulong J, Lamy T et al. Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling. Leukemia 2011, e-pub ahead of print 26 July 2011; doi:10.1038\/leu.2011.179.","journal-title":"Leukemia"},{"key":"BFbcj201153_CR15","first-page":"220","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"NL Harris","year":"2008","unstructured":"Harris NL, Swerdlow SH, Jaffe ES, Ott G, Nathwani BN, de Jong D et al. Follicular lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (eds). WHO classification of tumours of haematopoietic and lymphoid tissues, 4 edn. IARC: Lyon, 2008, pp 220\u2013226."},{"key":"BFbcj201153_CR16","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 2009; 27: 4555\u20134562.","journal-title":"J Clin Oncol"},{"key":"BFbcj201153_CR17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/10428190701704647","volume":"49","author":"E Kimby","year":"2008","unstructured":"Kimby E, Jurlander J, Geisler C, Hagberg H, Holte H, Lehtinen T et al. Long-term molecular remissions in patients with indolent lymphoma treated with rituximab as a single agent or in combination with interferon alpha-2a: a randomized phase II study from the Nordic Lymphoma Group. Leuk Lymphoma 2008; 49: 102\u2013112.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201153_CR18","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1158\/1078-0432.CCR-11-0264","volume":"17","author":"BE Wahlin","year":"2011","unstructured":"Wahlin BE, Sundstrom C, Holte H, Hagberg H, Erlanson M, Nilsson-Ehle H et al. T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab. Clin Cancer Res 2011; 17: 4136\u20134144.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201153_CR19","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.bcp.2003.07.008","volume":"66","author":"R Gamberale","year":"2003","unstructured":"Gamberale R, Galmarini CM, Fernandez-Calotti P, Jordheim L, Sanchez-Avalos J, Dumontet C et al. In vitro susceptibility of CD4+ and CD8+ T cell subsets to fludarabine. Biochem Pharmacol 2003; 66: 2185\u20132191.","journal-title":"Biochem Pharmacol"},{"key":"BFbcj201153_CR20","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3899\/jrheum.100729","volume":"38","author":"S Iwata","year":"2010","unstructured":"Iwata S, Saito K, Tokunaga M, Yamaoka K, Nawata M, Yukawa S et al. Phenotypic changes of lymphocytes in patients with systemic lupus erythematosus who are in longterm remission after B cell depletion therapy with rituximab. J Rheumatol 2010; 38: 633\u2013641.","journal-title":"J Rheumatol"},{"key":"BFbcj201153_CR21","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/sj.leu.2403844","volume":"19","author":"A Bognar","year":"2005","unstructured":"Bognar A, Csernus B, Bodor C, Reiniger L, Szepesi A, Toth E et al. Clonal selection in the bone marrow involvement of follicular lymphoma. Leukemia 2005; 19: 1656\u20131662.","journal-title":"Leukemia"},{"key":"BFbcj201153_CR22","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1182\/blood.V99.1.282","volume":"99","author":"H Husson","year":"2002","unstructured":"Husson H, Carideo EG, Neuberg D, Schultze J, Munoz O, Marks PW et al. Gene expression profiling of follicular lymphoma and normal germinal center B cells using cDNA arrays. Blood 2002; 99: 282\u2013289.","journal-title":"Blood"},{"key":"BFbcj201153_CR23","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.4049\/jimmunol.174.4.2021","volume":"174","author":"N Kienzle","year":"2005","unstructured":"Kienzle N, Olver S, Buttigieg K, Groves P, Janas ML, Baz A et al. Progressive differentiation and commitment of CD8+ T cells to a poorly cytolytic CD8low phenotype in the presence of IL-4. J Immunol 2005; 174: 2021\u20132029.","journal-title":"J Immunol"},{"key":"BFbcj201153_CR24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1365-2141.1992.tb06395.x","volume":"80","author":"S Petrasch","year":"1992","unstructured":"Petrasch S, Kosco M, Perez-Alvarez C, Schmitz J, Brittinger G . Proliferation of non-Hodgkin-lymphoma lymphocytes in vitro is dependent upon follicular dendritic cell interactions. Br J Haematol 1992; 80: 21\u201326.","journal-title":"Br J Haematol"},{"key":"BFbcj201153_CR25","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1111\/j.1365-2249.1993.tb05904.x","volume":"91","author":"E Lindhout","year":"1993","unstructured":"Lindhout E, Mevissen ML, Kwekkeboom J, Tager JM, de Groot C . Direct evidence that human follicular dendritic cells (FDC) rescue germinal centre B cells from death by apoptosis. Clin Exp Immunol 1993; 91: 330\u2013336.","journal-title":"Clin Exp Immunol"},{"key":"BFbcj201153_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S1044-5323(02)00058-1","volume":"14","author":"L Li","year":"2002","unstructured":"Li L, Choi YS . Follicular dendritic cell-signaling molecules required for proliferation and differentiation of GC-B cells. Semin Immunol 2002; 14: 259\u2013266.","journal-title":"Semin Immunol"},{"key":"BFbcj201153_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/0923-2494(91)90071-P","volume":"142","author":"LH Rademakers","year":"1991","unstructured":"Rademakers LH . Follicular dendritic cells in germinal centre development. Res Immunol 1991; 142: 257\u2013260.","journal-title":"Res Immunol"},{"key":"BFbcj201153_CR28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.4049\/jimmunol.160.3.1078","volume":"160","author":"ZF Kapasi","year":"1998","unstructured":"Kapasi ZF, Qin D, Kerr WG, Kosco-Vilbois MH, Shultz LD, Tew JG et al. Follicular dendritic cell (FDC) precursors in primary lymphoid tissues. J Immunol 1998; 160: 1078\u20131084.","journal-title":"J Immunol"},{"key":"BFbcj201153_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3109\/10428199809057595","volume":"31","author":"CD Weekes","year":"1998","unstructured":"Weekes CD, Pirruccello SJ, Vose JM, Kuszynski C, Sharp JG . Lymphoma cells associated with bone marrow stromal cells in culture exhibit altered growth and survival. Leuk Lymphoma 1998; 31: 151\u2013165.","journal-title":"Leuk Lymphoma"},{"key":"BFbcj201153_CR30","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1182\/blood-2006-05-020800","volume":"109","author":"P Ame-Thomas","year":"2007","unstructured":"Ame-Thomas P, Maby-El Hajjami H, Monvoisin C, Jean R, Monnier D, Caulet-Maugendre S et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 2007; 109: 693\u2013702.","journal-title":"Blood"},{"key":"BFbcj201153_CR31","doi-asserted-by":"publisher","first-page":"46701","DOI":"10.1074\/jbc.M103484200","volume":"276","author":"L Flaishon","year":"2001","unstructured":"Flaishon L, Lantner F, Hershkoviz R, Levo Y, Shachar I . Low levels of IFN-gamma down-regulate the integrin-dependent adhesion of B cells by activating a pathway that interferes with cytoskeleton rearrangement. J Biol Chem 2001; 276: 46701\u201346706.","journal-title":"J Biol Chem"},{"key":"BFbcj201153_CR32","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1084\/jem.20090303","volume":"206","author":"AG Zaretsky","year":"2009","unstructured":"Zaretsky AG, Taylor JJ, King IL, Marshall FA, Mohrs M, Pearce EJ . T follicular helper cells differentiate from Th2 cells in response to helminth antigens. J Exp Med 2009; 206: 991\u2013999.","journal-title":"J Exp Med"},{"key":"BFbcj201153_CR33","doi-asserted-by":"publisher","first-page":"3818","DOI":"10.1182\/blood-2008-02-138933","volume":"112","author":"KR Calvo","year":"2008","unstructured":"Calvo KR, Dabir B, Kovach A, Devor C, Bandle R, Bond A et al. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma. Blood 2008; 112: 3818\u20133826.","journal-title":"Blood"},{"key":"BFbcj201153_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1046\/j.1365-2141.2002.03832.x","volume":"119","author":"H Husson","year":"2002","unstructured":"Husson H, Freedman AS, Cardoso AA, Schultze J, Munoz O, Strola G et al. CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cells. Br J Haematol 2002; 119: 492\u2013495.","journal-title":"Br J Haematol"},{"key":"BFbcj201153_CR35","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1182\/blood-2004-03-1206","volume":"104","author":"CH Kim","year":"2004","unstructured":"Kim CH, Lim HW, Kim JR, Rott L, Hillsamer P, Butcher EC . Unique gene expression program of human germinal center T helper cells. Blood 2004; 104: 1952\u20131960.","journal-title":"Blood"},{"key":"BFbcj201153_CR36","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1084\/jem.192.11.1545","volume":"192","author":"D Breitfeld","year":"2000","unstructured":"Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000; 192: 1545\u20131552.","journal-title":"J Exp Med"},{"key":"BFbcj201153_CR37","doi-asserted-by":"publisher","first-page":"5522","DOI":"10.1158\/0008-5472.CAN-09-0266","volume":"69","author":"ZZ Yang","year":"2009","unstructured":"Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM . Malignant B cells skew the balance of regulatory T cells and TH17 cells in B-cell non-Hodgkin\u2032s lymphoma. Cancer Res 2009; 69: 5522\u20135530.","journal-title":"Cancer Res"},{"key":"BFbcj201153_CR38","doi-asserted-by":"publisher","first-page":"10145","DOI":"10.1158\/0008-5472.CAN-06-1822","volume":"66","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Ziesmer SC, Witzig TE, Ansell SM . Attenuation of CD8(+) T-cell function by CD4(+)CD25(+) regulatory T cells in B-cell non-Hodgkin\u2032s lymphoma. Cancer Res 2006; 66: 10145\u201310152.","journal-title":"Cancer Res"},{"key":"BFbcj201153_CR39","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.1182\/blood-2005-08-3376","volume":"107","author":"ZZ Yang","year":"2006","unstructured":"Yang ZZ, Novak AJ, Stenson MJ, Witzig TE, Ansell SM . Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma. Blood 2006; 107: 3639\u20133646.","journal-title":"Blood"},{"key":"BFbcj201153_CR40","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.4049\/jimmunol.178.7.4051","volume":"178","author":"SP Hilchey","year":"2007","unstructured":"Hilchey SP, De A, Rimsza LM, Bankert RB, Bernstein SH . Follicular lymphoma intratumoral CD4+CD25+GITR+ regulatory T cells potently suppress CD3\/CD28-costimulated autologous and allogeneic CD8+CD25- and CD4+CD25- T cells. J Immunol 2007; 178: 4051\u20134061.","journal-title":"J Immunol"},{"key":"BFbcj201153_CR41","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1182\/blood-2009-04-217687","volume":"114","author":"AG Ramsay","year":"2009","unstructured":"Ramsay AG, Clear AJ, Kelly G, Fatah R, Matthews J, Macdougall F et al. Follicular lymphoma cells induce T-cell immunologic synapse dysfunction that can be repaired with lenalidomide: implications for the tumor microenvironment and immunotherapy. Blood 2009; 114: 4713\u20134720.","journal-title":"Blood"},{"issue":"13","key":"BFbcj201153_CR42","doi-asserted-by":"publisher","first-page":"3591","DOI":"10.1182\/blood-2011-03-340646","volume":"118","author":"S. P. Hilchey","year":"2011","unstructured":"Hilchey SP, Rosenberg AF, Hyrien O, Secor-Socha S, Cochran MR, Brady MT et al. Follicular lymphoma tumor infiltrating T-helper (TH) cells have the same polyfunctional potential as normal nodal TH cells despite skewed differentiation. Blood 2011, E-pub ahead of print 5 August 2011; doi: 10.1182\/blood-2011-03-340646.","journal-title":"Blood"},{"key":"BFbcj201153_CR43","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1182\/blood-2004-03-1110","volume":"104","author":"G Cartron","year":"2004","unstructured":"Cartron G, Watier H, Golay J, Solal-Celigny P . From the bench to the bedside: ways to improve rituximab efficacy. Blood 2004; 104: 2635\u20132642.","journal-title":"Blood"},{"key":"BFbcj201153_CR44","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1182\/blood-2008-10-185280","volume":"113","author":"SP Hilchey","year":"2009","unstructured":"Hilchey SP, Hyrien O, Mosmann TR, Livingstone AM, Friedberg JW, Young F et al. Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a \u2033vaccinal effect\u2033 of rituximab. Blood 2009; 113: 3809\u20133812.","journal-title":"Blood"},{"key":"BFbcj201153_CR45","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood.V67.6.1600.1600","volume":"67","author":"P Clark","year":"1986","unstructured":"Clark P, Normansell DE, Innes DJ, Hess CE . Lymphocyte subsets in normal bone marrow. Blood 1986; 67: 1600\u20131606.","journal-title":"Blood"},{"key":"BFbcj201153_CR46","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2249.1992.tb03068.x","volume":"88","author":"M Bofill","year":"1992","unstructured":"Bofill M, Janossy G, Lee CA, MacDonald-Burns D, Phillips AN, Sabin C et al. Laboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis. Clin Exp Immunol 1992; 88: 243\u2013252.","journal-title":"Clin Exp Immunol"},{"key":"BFbcj201153_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/j.1749-6632.1993.tb38799.x","volume":"677","author":"CF Bryan","year":"1993","unstructured":"Bryan CF, Eastman PJ, Conner JB, Baier KA, Durham JB . Clinical utility of a lymph node normal range obtained by flow cytometry. Ann NY Acad Sci 1993; 677: 404\u2013406.","journal-title":"Ann NY Acad Sci"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bcj201153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bcj201153","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201153.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T22:39:12Z","timestamp":1672958352000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,20]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2012,1]]}},"alternative-id":["BFbcj201153"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2011.53","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,20]]},"assertion":[{"value":"18 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}